This paper is in the following e-collection/theme issue:

Pilot studies (ehealth) (215) Knowledge Translation and Implementation Science (407) Patient-Reported Outcome Measures (PROMs) (294) User-centred Design Case Studies (602) Design and Formative Evaluation of Mobile Apps (706) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1428) Innovations and Technology in Cancer Care (431) Mobile Apps for Cancer Care and Cancer Prevention and Screening (210)

Published on in Vol 4, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/18982, first published .
Adaptation and Evaluation of a Symptom-Monitoring Digital Health Intervention for Patients With Relapsed and Refractory Multiple Myeloma: Pilot Mixed-Methods Implementation Study

Adaptation and Evaluation of a Symptom-Monitoring Digital Health Intervention for Patients With Relapsed and Refractory Multiple Myeloma: Pilot Mixed-Methods Implementation Study

Adaptation and Evaluation of a Symptom-Monitoring Digital Health Intervention for Patients With Relapsed and Refractory Multiple Myeloma: Pilot Mixed-Methods Implementation Study

Authors of this article:

Noa Biran1 Author Orcid Image ;   Robin Anthony Kouyaté2 Author Orcid Image ;   Emre Yucel2 Author Orcid Image ;   Gillian E McGovern3 Author Orcid Image ;   Antoinette M Schoenthaler4 Author Orcid Image ;   Olivia G Durling3 Author Orcid Image ;   Rashmi Unawane1 Author Orcid Image ;   Andrew Schutt5 Author Orcid Image ;   Sumeet Panjabi2 Author Orcid Image
Article Authors Cited by (12) Tweetations (3) Metrics

Noa Biran   1 , MD ;   Robin Anthony Kouyaté   2 , PhD ;   Emre Yucel   2 , PhD, MPEE, MPCP, MIB, PHARM ;   Gillian E McGovern   3 , MPH ;   Antoinette M Schoenthaler   4 , EdD ;   Olivia G Durling   3 , BS ;   Rashmi Unawane   1 , MBBS ;   Andrew Schutt   5 , MSc ;   Sumeet Panjabi   2 , PhD

1 Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, United States

2 Amgen Inc, Thousand Oaks, CA, United States

3 Rip Road Inc, New York, NY, United States

4 Department of Population Health, NYU School of Medicine, New York, NY, United States

5 Medocity Inc, Parsippany, NJ, United States

Corresponding Author: